Clinical Trials Directory

Trials / Unknown

UnknownNCT06054139

Risk Factors for Refeeding Syndrome in the Surgical Intensive Care Unit

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Samsun University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Refeeding Syndrome is a condition that occurs when patients who are undernourished or undernourished suddenly start overfeeding, causing electrolyte disturbances and vitamin deficiencies, resulting in neurological and cardiac problems. It may even result in death. It is aimed to prevent the development of Refeeding Syndrome with nutrition in accordance with the guidelines. The aim of this study is to determine the risk factors for Refeeding Syndrome in Intensive Care Unit (ICU).

Detailed description

Nutritional support is an important part of treatment in intensive care patients. Especially existing comorbidities and developing acute problems before intensive care admission can cause serious malnutrition for patients. Refeeding syndrome is a serious, life-threatening condition accompanied by electrolyte and metabolic disorders as a result of rapid re-feeding following prolonged starvation or malnutrition. The condition may be accompanied by electrolyte disorders such as hypophosphatemia, hypokalemia and hypomagnesemia, as well as decrease in vitamin levels (especially vitamin B1), fluid imbalance and salt retention. The resulting imbalances can cause cardiac and neurological side effects, impaired organ functions and even death. The refeeding protocol should be individualized to each patient's clinical situation. In this study, although nutritional protocols in accordance with the guidelines are applied in patients with risk factors for the development of Refeeding Syndrome, whether Refeeding Syndrome develops and the facilitating factors will be investigated in ICU.

Conditions

Interventions

TypeNameDescription
OTHERRefeeding SyndromePatients who developed Refeeding Syndrome despite proper nutrition while receiving treatment in the ICU

Timeline

Start date
2023-06-09
Primary completion
2024-06-09
Completion
2024-07-09
First posted
2023-09-26
Last updated
2023-09-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06054139. Inclusion in this directory is not an endorsement.